Advancing Pharmacovigilance Through The Use Of Machine Learning (ml) And Real-world Data (RWD)
November 14-15, 2023 | USA
The objective of this webinar is to discuss both the science and regulatory challenges in two areas of research that have great potential to advance the identification and assessment of drug-related adverse events. ML, a type of artificial intelligence, is showing promise as a tool to enhance drug causality assessments, among other areas in the PV life cycle.